FDA NDC Directory · JSON-LD · Markdown

GARDASIL

NDC 0006-4109 · VACCINE · INJECTION, SUSPENSION

Generic nameHuman Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
Labeler / ManufacturerMerck Sharp & Dohme LLC
Marketing categoryBiologic License Application · App BLA125126
Dosage form / routeINJECTION, SUSPENSION · INTRAMUSCULAR
Active ingredientsHUMAN PAPILLOMAVIRUS TYPE 11 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN ANTIGEN (40 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL)
HUMAN PAPILLOMAVIRUS TYPE 6 L1 CAPSID PROTEIN ANTIGEN (20 ug/.5mL)
Marketing started20060608
Package count2

External sources

Source: openFDA. Public-domain (CC0).